Related Experiment Video
Updated: Jan 24, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Nonpharmacological therapies for interstitial lung disease
1Associate Professor of Medicine, Clinical Nurse Specialist, Executive Director SUPPORT Program, University of Pittsburgh Dorothy P. & Richard P. Simmons, Center for Interstitial Lung Disease at UPMC, NW 628, UPMC Montefiore, 3459 Fifth Avenue, Pittsburgh, PA 15213, lindellko@upmc.edu.
A Purpose Of Review:
Interstitial lung diseases (ILDs) cause unpredictable degrees of fibrosis and inflammation in the lungs leading to functional decline and varying symptom burden for patients. Some patients may live for years and be responsive to therapy and others disease trajectory may be shorter and similar to patients with lung cancer. This ultimately affects the patient's quality of life as well as their caregiver(s).
B Recent Findings:
Nonpharmacological therapies play an important role in treatment of interstitial lung disease. These include symptom management, pulmonary rehabilitation, oxygen therapy, and palliative care. While ILDs are associated with high morbidity and mortality, different models of care exist globally. New tools help clinicians identify and address palliative care needs in daily practice and specialty nurses and ILD centers can optimize care.
C Summary:
This paper provides an overview of nonpharmacological therapies available for patients with interstitial lung disease.
Related Concept Videos
Lung Capacity
Gene Therapy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Group Therapy
Psychodynamic Therapy
Humanistic Therapy

